Member Info for Latino

This has dropped to the SP before the big RNS last Nov and also it’s under the placing price…is as we’re back to square one, completely disregarding the CE certification that took this from these levels to 79p….welcome to AIM!

After flurry of early trades, very quite day and not much excitement. Hopefully clear out seller tomorrow, and news.

Further news due…

RNS is overdue so anytime now…surely people in the know will be buying before RNS..

Would make sense to, it’s a last placing price 80 - 25p hell of a drop…to add with no news!

If this was the case then GDR would have had to RNS this…as per the rules as this would price sensitive news.

Overdue RNS coming??

Shorters if there are any, should exit now. This surely cannot go any further down unless the RNS warrants it. Worst scenario of no sales yet is already priced in the SP in my view!

Possibly, but the placing circular will have to come first.

For a start update on what he said in the Nov RNS…active interest from commercial partners

As detailed in the announcement on 29 November, the product is being provided for review and evaluation to a range of potential commercial partners who have actively expressed interest in the product with regards to European opportunities.

Most frustrating CEO out there…when he should be shouting from roof top, he choses to go completely silent. Hope it’s going to be worth the wait!

No way that was a buy, watched some from start never dropped to 20p to but let alone 17p…unless it was somehow in the dark!

Flushing traders lol…guys who only hold for a few hours had to hold all weekend, so must have been anxious wait for them to sell asap!

CEO so inept here anything is possible now…

Stuck in here since Friday lol

Even Sensyne Health’s most stupid artificial intelligence algorithms must have worked it out by now: the “clinical AI” group’s boss, Lord Drayson, should not be allowed anywhere near a publicly quoted company.

How much more proof does anyone need? Even by his usual standards, his latest howitzer is a jaw-dropper, driven home by a 71.5 per cent dive in the shares to 21½p, valuing the group at just £35 million. In fact his update is a vignette of Drayson’s style: three pages of wishful thinking, with the key point buried at the end. What’s that, you ask? That, oh, by the way, Sensyne will run out of money by early Feb.

https://www.thetimes.co.uk/article/sensyne-healthier-without-drayson-vdt82ptgg

US bidders coming in keep an eye out!

Meant tranche 1 which is some 12.7% of issued shares, the 2nd tranche which is 5% this is subjective and may not be needed.

BoD orchestrated drop for buy out…or will a competitor beat and out bid them. Expecting new buyers to bid as the business is sound and appealing, with many NDAs and many collaborations already in place.

Something not right here…!